These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35601676)

  • 1. Sinus Bradycardia in an Adolescent Taking Lamotrigine.
    Davis G; Ward K; Mohiuddin S
    Case Rep Psychiatry; 2022; 2022():3353684. PubMed ID: 35601676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    Pharmacotherapy; 2020 Feb; 40(2):107-115. PubMed ID: 31867748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Is It Her Hormones?": Psychiatric Diagnoses and Polycystic Ovarian Syndrome.
    Genovese A; Smith T; Kramer H; Augustyn M
    J Dev Behav Pediatr; 2016 Jan; 37(1):103-4. PubMed ID: 26703328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
    Marangell LB; Martinez JM; Ketter TA; Bowden CL; Goldberg JF; Calabrese JR; Miyahara S; Miklowitz DJ; Sachs GS; Thase ME;
    Bipolar Disord; 2004 Apr; 6(2):139-43. PubMed ID: 15005752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine in psychiatric disorders.
    Reid JG; Gitlin MJ; Altshuler LL
    J Clin Psychiatry; 2013 Jul; 74(7):675-84. PubMed ID: 23945444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine augmentation strategy for patients with treatment-resistant depression.
    Gutierrez RL; McKercher RM; Galea J; Jamison KL
    CNS Spectr; 2005 Oct; 10(10):800-5. PubMed ID: 16400242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine may Increase Risk of Arrythmias.
    Aschenbrenner DS
    Am J Nurs; 2021 Aug; 121(8):23. PubMed ID: 34819469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
    J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delirium Secondary to Lamotrigine Toxicity.
    Sanchez DL; Fusick AJ; Gunther SR; Hernandez MJ; Sullivan GA; Catalano MC; Catalano G
    Curr Drug Saf; 2020; 15(2):156-159. PubMed ID: 32096747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine augmentation in unipolar depression.
    Rocha FL; Hara C
    Int Clin Psychopharmacol; 2003 Mar; 18(2):97-9. PubMed ID: 12598821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens Johnson Syndrome associated with Lamotrigine.
    Parveen S; Javed MA
    Pak J Med Sci; 2013 Nov; 29(6):1450-2. PubMed ID: 24550973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine for people with borderline personality disorder: a RCT.
    Crawford MJ; Sanatinia R; Barrett B; Cunningham G; Dale O; Ganguli P; Lawrence-Smith G; Leeson VC; Lemonsky F; Lykomitrou-Matthews G; Montgomery A; Morriss R; Munjiza J; Paton C; Skorodzien I; Singh V; Tan W; Tyrer P; Reilly JG
    Health Technol Assess; 2018 Apr; 22(17):1-68. PubMed ID: 29651981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradycardia following oral corticosteroid use: case report and literature review.
    Al Shibli A; Al Attrach I; Hamdan MA
    Arab J Nephrol Transplant; 2012 Jan; 5(1):47-9. PubMed ID: 22283866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
    Kundu A; Fitzgibbons TP
    J Med Case Rep; 2015 Sep; 9():216. PubMed ID: 26400725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine in rapid-cycling bipolar disorder.
    Fatemi SH; Rapport DJ; Calabrese JR; Thuras P
    J Clin Psychiatry; 1997 Dec; 58(12):522-7. PubMed ID: 9448654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: a retrospective cohort study.
    Tak HJ; Ahn JH; Kim KW; Kim Y; Choi SW; Lee KY; Park EJ; Bhang SY
    Psychiatry Investig; 2012 Jun; 9(2):174-9. PubMed ID: 22707969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone-Induced Symptomatic Sinus Bradycardia in a Multiple Sclerosis Patient: A Case Report.
    Miqdad MA; Mohamad A; Ali F; Mourad AR; Alamri A
    Cureus; 2022 Jan; 14(1):e21443. PubMed ID: 35223228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine as an augmentation agent in treatment-resistant depression.
    Barbee JG; Jamhour NJ
    J Clin Psychiatry; 2002 Aug; 63(8):737-41. PubMed ID: 12197456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.